Cerus to Present Cryoprecipitate Comparison Study in Liver Transplantation at 2026 AABB Meeting

Cerus will present transfusion research at the AABB Annual Meeting in Atlanta, Oct. 17-19, 2026. Oral presentations will address platelet bacterial contamination on Oct. 17 and compare pathogen-reduced versus conventional cryoprecipitate in liver transplantation on Oct. 19. An Oct. 18 workshop will examine Grady Health System's real-world experience implementing INTERCEPT Platelets and INTERCEPT Fibrinogen Complex. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cerus Corporation published the original content used to generate this news brief via (Ref. ID: 20261014682249) on October 14, 2026, and is solely responsible for the information contained therein. (C)